NCT00098813View on ClinicalTrials.gov

Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer
Interventions
DRUG

romidepsin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

PROCEDURE

positron emission tomography

Correlative studies

Trial Locations (1)

11725

Memorial Sloan-Kettering Cancer Center at Suffolk, Commack

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00098813 - Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine | Biotech Hunter | Biotech Hunter